Illumina ramped up its US lobbying spend in Washington, DC, in recent months, hiring law firms Sidley Austin and DLA Piper to advocate for the biotechnology company as it prepares to contest a Federal Trade Commission (FTC) antitrust complaint at trial in August, according to Reuters.
The FTC’s administrative complaint, filed in March, said San Diego-based Illumina’s proposed US$7.1 billion acquisition of GRAIL would harm innovation in the market for “multi-cancer early detection” tests and drive up prices. GRAIL, which makes a non-invasive biopsy test, and its competitors rely on Illumina technology, the agency stated.
Companies facing regulatory or enforcement scrutiny often boost outside advocacy efforts. Illumina spent US$360,000 on US lobbying in the second quarter, including US$150,000 for Sidley Austin government affairs services and US$40,000 for DLA Piper, which was hired in July. The firms stated in disclosures they were lobbying in Congress to support Illumina’s acquisition of GRAIL.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
T-Mobile Faces Class-Action Lawsuit Over Sprint Merger After Appeal Denied
May 16, 2024 by
CPI
Google Faces Backlash Over Introduction of AI-Generated Summaries in Searches
May 16, 2024 by
CPI
CMA Launches Phase 2 Probe into AlphaTheta’s Acquisition of Serato
May 16, 2024 by
CPI
NFL Executive Escapes Testifying in High-Stakes Trial Over Televised Games
May 16, 2024 by
CPI
EU Consumers Lodge Complaint Against Chinese Retailer Temu Over Content Rules Breach
May 16, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI